CardioLogs ECG Analysis Platform vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

CardioLogs ECG Analysis Platform is designed for rapid, AI-powered detection of arrhythmias from ECG data, making it suitable for practices focused on rhythm disorders. Autoplaque, conversely, specializes in quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, serving clinicians focused on assessing atherosclerotic disease and heart attack risk.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is rapid and accurate AI-powered analysis of ECG data for arrhythmia detection and diagnosis across a variety of cardiac monitoring devices. This cloud-based solution is ideal for practices requiring efficient processing of high volumes of ECGs, including those from Holter monitors, smartwatches, and ECG patches, to streamline diagnostic workflows.

View CardioLogs ECG Analysis Platform →

Choose Autoplaque if…

Choose Autoplaque if your focus is on detailed, quantitative analysis of coronary plaques and luminal stenoses from CT angiography images to assess heart attack risk and guide treatment. This workstation-based software is best suited for cardiologists and radiologists who require precise measurements and characterization of atherosclerotic disease within the coronary arteries.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform Autoplaque
Deployment Cloud-based Workstation-based post-processing application, runs on Windows or Mac OS.
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

CardioLogs is a cloud-based SaaS platform with multi-device compatibility and EHR integration, offering greater accessibility and seamless workflow integration. Autoplaque is workstation-based, which can be less flexible and require more local IT management.

Clinical Value

Tie

Both tools are FDA-cleared and provide significant clinical value in cardiology, but address different diagnostic areas. CardioLogs focuses on arrhythmia detection from ECGs, while Autoplaque specializes in quantitative coronary plaque analysis from CT angiography for risk prediction.

Pricing & Value

CardioLogs ECG Analysis Platform

CardioLogs provides a transparent pricing model, indicating a 'pay per ECG regardless of the number of users,' even if the exact cost requires contacting sales. Autoplaque's pricing is not disclosed, making it impossible to assess its value proposition.

Enterprise Readiness

CardioLogs ECG Analysis Platform

CardioLogs offers a cloud-based SaaS deployment, explicit HIPAA compliance, likely BAA, ISO/IEC 27001 certification, and EHR integration, making it highly suitable for enterprise environments. Autoplaque is workstation-based and lacks specified HIPAA compliance or BAA details.

Innovation

CardioLogs ECG Analysis Platform

CardioLogs leverages deep neural networks for ECG analysis across diverse devices, including smartwatches, and utilizes a cloud-native architecture, demonstrating a broader innovative approach to cardiac diagnostics. Autoplaque's quantitative plaque analysis is innovative but its workstation-based deployment is less forward-thinking in terms of platform architecture.

Support & Docs

CardioLogs ECG Analysis Platform

Philips (CardioLogs) explicitly mentions a 'Support Center,' 'technical support' accessible via the platform's 'Help' menu, and 'Product manuals & resources'. For Autoplaque, while a user manual is implied, there is no readily available information on dedicated customer support channels or public documentation portals.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform Autoplaque
Name CardioLogs ECG Analysis Platform Autoplaque
Company Cardiologs Technologies (now part of Philips) Cedars-Sinai Medical Center: AIM
Primary Function/Category AI-powered ECG analysis for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.
Key Technology/Method AI-Powered ECG Analysis (Deep Neural Networks). AI-powered quantitative analysis of atherosclerotic plaque.
Data Input Type ECG data from various cardiac monitoring devices (Holter, smartwatches, ECG patches). CT angiography images.
Target Output Automated arrhythmia detection (e.g., AFib, VT), customizable reports, real-time monitoring/analysis. Detection and characterization of coronary artery plaque, measurement of luminal stenoses, analysis of coronary anatomy and pathology, aiding in heart attack risk prediction and treatment guidance.

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and Autoplaque.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform analyzes ECG data from various cardiac monitoring devices, such as Holter monitors, smartwatches, and ECG patches, to aid in arrhythmia detection and diagnosis. Autoplaque analyzes CT angiography images for quantitative assessment of coronary plaques and luminal stenoses.
CardioLogs ECG Analysis Platform focuses on rapid, accurate, and efficient analysis of ECG data for automated arrhythmia detection, including AFib and VT. Autoplaque provides AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, and measurement of luminal stenoses from CT Angiographic images, aiding in heart attack risk prediction and treatment guidance.
CardioLogs ECG Analysis Platform lists integration with EHR systems as a key feature. Integration with EHR systems is not specified for Autoplaque.
AI Tool Finder
AI-powered search. Results may not be comprehensive.